The validation of artificial anti‐monkeypox antibodies by in silico and experimental approaches
Abstract As a result of smallpox immunization programs that ended more than 40 years ago, a significant portion of the world's population is not immune. Moreover, due to the lack of anti‐monkeypox drugs and vaccines against monkeypox, the spread of this virus may be the beginning of another cha...
Saved in:
| Main Authors: | Sadeq Shabani, Mohsen Rashidi, Shakila Radgoudarzi, Ali Jebali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-04-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.834 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Silico Analysis of Ergosterol as Antiviral Agents Targeting Monkeypox Methyltransferase, Phosphatase and A42R Profilin-like Protein Receptors
by: Kaymak Sibel, et al.
Published: (2025-07-01) -
Levels of antibodies against the monkeypox virus compared by HIV status and historical smallpox vaccinations: a serological study
by: Dapeng Li, et al.
Published: (2024-12-01) -
Exploring monkeypox virus antibody levels: insights from human immunological research
by: Jing Wu, et al.
Published: (2025-05-01) -
Correlation between microneutralization test and a multiplexed immunoassay for evaluation of monkeypox and vaccinia virus antibodies before and after smallpox vaccination
by: Serena Marchi, et al.
Published: (2025-06-01) -
Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic development
by: Jing Liu, et al.
Published: (2025-02-01)